T1	Participants 79 145	children and adolescents with Stages I, IIA, IIIA1 Hodgkin Disease
T2	Participants 422 547	Children < or =21 years old with biopsy-proven, pathologically staged I, IIA, or IIIA1 Hodgkin disease were randomly assigned
T3	Participants 1211 1296	pediatric patients with asymptomatic low-stage and intermediate-stage Hodgkin disease
